Bipolar Disorder: Causes, Neurotransmitters, and Treatment
Bipolar disorder affects approximately 1% of the population and is characterized by alternating episodes of depression, mania, or hypomania. This paper examines the multifactorial etiology of bipolar disorder, including genetic influences (accounting for 60–80% of risk), physiological abnormalities in brain structure and function, environmental stressors, neurological conditions, and neurotransmitter dysfunction. The paper discusses how dopamine, glutamate, and GABA dysregulation contribute to mood cycling, explores diagnostic challenges due to symptom overlap with other psychiatric disorders, and reviews available pharmacological treatments including anticonvulsants, antipsychotics, and lithium. Despite extensive research, no single cause has been identified, and treatment remains symptom-focused rather than curative.
- Overview and Epidemiology: Definition, prevalence, onset age, and multifactorial causes
- Genetic Influences: Heritability rates and specific gene variants
- Physiological and Brain Structure Factors: Brain imaging findings and neurotransmitter abnormalities
- Environmental and Neurological Factors: Trauma, HPA axis dysfunction, and acquired conditions
- Neurotransmitter Dysfunction: Dopamine, GABA, and glutamate dysregulation in mood cycling
- Diagnosis and Treatment: Diagnostic challenges and available pharmacological interventions
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Comprehensive multifactorial approach: The paper systematically covers genetic, physiological, environmental, and neurological contributors rather than reducing bipolar disorder to a single cause.
- Specific neurobiological detail: References to brain regions (lateral ventricles, globus pallidus, amygdala), neurotransmitter systems, and molecular mechanisms (sodium ATPase pump, mitochondrial dysfunction) provide concrete evidence for claims.
- Clear integration of quoted evidence: The paper effectively embeds citations like the dopamine hypothesis and HPA axis dysfunction to support mechanistic explanations.
- Acknowledgment of diagnostic complexity: The discussion of symptom overlap with other psychiatric disorders (schizophrenia, ADHD, borderline personality disorder) demonstrates clinical awareness.
Key academic technique demonstrated
The paper employs a disease etiology framework—organizing information along multiple causative pathways (genetic, physiological, environmental, neurological) rather than chronologically or by severity. This structure allows readers to understand how different mechanisms may interact (e.g., genetic predisposition + environmental stress) and reflects how modern psychiatry conceptualizes complex disorders. The technique is reinforced through strategic use of prevalence data and quantified risk percentages (60–80% genetic contribution, 30–50% childhood trauma correlation), which anchor abstract concepts to measurable facts.
Structure breakdown
The paper opens with a clinical definition and epidemiology (who is affected, when onset occurs), then progressively deepens mechanistic understanding: macro-level genetics → structural brain changes → molecular/neurochemical dysfunction → clinical challenges and management. The conclusion cycles back to the lived experience of patients managed through treatment, creating coherence between bench science and bedside reality. This movement from population-level prevalence through molecular detail and back to patient outcomes is characteristic of upper-level undergraduate health science writing.
Overview and Epidemiology
Bipolar disorder is characterized by transitions between depression and mania or hypomania, depending on severity. Individuals who experience manic episodes also experience depressive episodes or symptoms, or mixed episodes in which both mania and depression are present simultaneously. These episodes are usually separated by periods of normal mood, but in some individuals, depression and mania may rapidly alternate, a condition known as rapid cycling.
Over 3 million Americans, approximately 1% of the population (or 1 in every 100 people), suffer from bipolar disorder, with similar rates reported in other countries. Bipolar disorder occurs equally among males and females, and often begins between the ages of 15 and 24. While the exact cause of this disorder remains unclear, several factors are known to contribute to its development, including genetic, physiological, environmental, neurological, and neuroendocrinological influences.
Genetic Influences
Genetic influences are believed to account for 60 to 80% of the risk for developing bipolar disorder. Although scientists have been unable to pinpoint a specific gene responsible for the disorder, their findings have concluded that variants within the genes CACNA1C, ODZ4, and NCAN can be major factors in its development. An increase in these genetic mutations has been linked to advanced paternal age, leading to an increased risk of bipolar disorder development in offspring (Kerner 2014).
Physiological and Brain Structure Factors
Physiological influences, including abnormalities in the structure and function of certain brain circuits, play a major role in the development of bipolar disorder. Brain imaging studies have demonstrated an increase in the volume of the lateral ventricles, globus pallidus, and rates of deep white matter hyperintensities. These studies also suggest that abnormal modulation between the ventral prefrontal and limbic regions, including the amygdala, contributes to poor emotional regulation and mood instabilities (Goodwin & Jamison 2007).
Alterations to mitochondrial function and the sodium ATPase pump are also believed to cause poor neuron firing and hypersensitive neuron firing, resulting in periods of depression and mania. These cellular-level dysfunctions provide a mechanistic explanation for the observable mood fluctuations characteristic of bipolar disorder.
Neurotransmitter Dysfunction
Scientists have determined that three neurotransmitters are involved in bipolar disorder: dopamine, glutamate, and gamma-aminobutyric acid (GABA). Dopamine is responsible for mood regulation and has increased transmission during the manic phase. "The dopamine hypothesis states that the increase in dopamine results in secondary homeostatic down-regulation of key systems and receptors such as an increase in dopamine-mediated G protein-coupled receptors" (Sedler 2010). This decrease in dopamine transmission causes the depressive phase, and when the depressive phase ends, the cycle starts over again.
Glutamate and GABA, the other neurotransmitters involved, cause elevated mood states. Glutamate increases in the left dorsolateral prefrontal cortex during the manic phase and returns to normal when the phase is over. GABA, also increased during mood episodes, causes a decrease in GABA B receptors, which results in an abnormality in the layering of brain structures associated with the cerebral cortex (Serretti & Mandelli 2008).
Always verify citation format against your institution’s current style guide requirements.